1 Product identity
Ingredient risk
No flagged ingredients
CapraZyme
BrandDoctor's Choice Naturally →Other Combinations Capsule 20 ingredients DSLD #320510Net contents: 90 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2025-01-23
2 Ingredients (20)
IngredientGroupSafety
Plant Enzyme BlendBlend—
LipaseLipase—
AmylaseAmylase—
ProteaseProteolytic Enzymes (Proteases)—
CellulaseCellulase—
Malt DiastaseMalt Diastase—
Botanical BlendBlend—
GrapefruitGrapefruit—
GingerGinger —
YuccaYucca—
Aloe veraAloe—
Vegetable CelluloseCellulose—
HypromelloseHypromellose—
WaterWater—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Bromelain — Conditionally Safe
⚠ Increased bleeding risk
⚠ GI upset
Lactase — Generally Safe
⚠ Very well tolerated
⚠ Fungal-derived: rare allergy
Papain — Conditionally Safe
⚠ Allergic reactions
⚠ Increased bleeding risk
L-Glutamine — Conditionally Safe
⚠ Hepatic encephalopathy risk
⚠ May elevate ammonia
Cat's Claw — Limited Evidence
⚠ May worsen insulin resistance
⚠ Liver fat accumulation
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID320510
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2025-01-23
6 More from Doctor's Choice Naturally
7 Cite this page
Vancouver
Pkhakadze G. CapraZyme — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 25]. Available from: https://supplement.ge/products/caprazyme-320510/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG